Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory A Yanik

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2016
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant RecipientsElizabeth A Belloli, Irina Degtiar, Xin Wang, et al.
Blood|July 31, 2008
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationGregory A Yanik, Vincent T Ho, John E Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Blood Advances|June 24, 2025
Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host diseaseHusham Sharifi, Carson Tyler Moss, Zayan Musa, et al.
Blood Advances|January 26, 2021
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapyJochen Buechner, Stephan A Grupp, Hidefumi Hiramatsu, et al.
Pediatric Blood & Cancer|September 11, 2018
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastomaElizabeth A Sokol, Roger Engelmann, Wenjun Kang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical TrialCarrie L Kitko, Thomas Braun, Daniel R Couriel, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyJane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
Respiratory Medicine|September 3, 2025
Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive reviewChristopher Bertini, Felipe Soto, Rebecca Brown, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Pilot study of iodine-131-metaiodobenzylguanidine in combination with myeloablative chemotherapy and autologous stem-cell support for the treatment of neuroblastomaGregory A Yanik, John E Levine, Katherine K Matthay, et al.
American Journal of Respiratory and Critical Care Medicine|October 26, 2016
Parametric Response Mapping as an Imaging Biomarker in Lung Transplant RecipientsElizabeth A Belloli, Irina Degtiar, Xin Wang, et al.
Blood|July 31, 2008
The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantationGregory A Yanik, Vincent T Ho, John E Levine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium StudyKatherine K Matthay, Jessica C Tan, Judith G Villablanca, et al.
Blood Advances|June 24, 2025
Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host diseaseHusham Sharifi, Carson Tyler Moss, Zayan Musa, et al.
Blood Advances|January 26, 2021
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapyJochen Buechner, Stephan A Grupp, Hidefumi Hiramatsu, et al.
Pediatric Blood & Cancer|September 11, 2018
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastomaElizabeth A Sokol, Roger Engelmann, Wenjun Kang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Combination Therapy for Graft-versus-Host Disease Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical TrialCarrie L Kitko, Thomas Braun, Daniel R Couriel, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2011
Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium studyJane E Minturn, Audrey E Evans, Judith G Villablanca, et al.
Respiratory Medicine|September 3, 2025
Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive reviewChristopher Bertini, Felipe Soto, Rebecca Brown, et al.
Pageof 8